Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Cited In for PubMed (Select 11079490)

1.

Advances in PET imaging of P-glycoprotein function at the blood-brain barrier.

Syvänen S, Eriksson J.

ACS Chem Neurosci. 2013 Feb 20;4(2):225-37. doi: 10.1021/cn3001729. Epub 2012 Dec 4. Review.

2.

5-HT radioligands for human brain imaging with PET and SPECT.

Paterson LM, Kornum BR, Nutt DJ, Pike VW, Knudsen GM.

Med Res Rev. 2013 Jan;33(1):54-111. doi: 10.1002/med.20245. Epub 2011 Jun 14. Review.

3.

Clinical translation of neuroimaging research in mood disorders.

Konarski JZ, McIntyre RS, Soczynska JK, Bottas A, Kennedy SH.

Psychiatry (Edgmont). 2006 Feb;3(2):46-57.

4.

Measuring endogenous 5-HT release by emission tomography: promises and pitfalls.

Paterson LM, Tyacke RJ, Nutt DJ, Knudsen GM.

J Cereb Blood Flow Metab. 2010 Oct;30(10):1682-706. doi: 10.1038/jcbfm.2010.104. Epub 2010 Jul 28. Review.

5.

PET radiotracers: crossing the blood-brain barrier and surviving metabolism.

Pike VW.

Trends Pharmacol Sci. 2009 Aug;30(8):431-40. doi: 10.1016/j.tips.2009.05.005. Epub 2009 Jul 16. Review.

6.

Antagonist but not agonist labeling of serotonin-1A receptors is decreased in major depressive disorder.

Stockmeier CA, Howley E, Shi X, Sobanska A, Clarke G, Friedman L, Rajkowska G.

J Psychiatr Res. 2009 Jul;43(10):887-94. doi: 10.1016/j.jpsychires.2009.01.001. Epub 2009 Feb 12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk